Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:378-379

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dana, A.
Right arrow Articles by Gioffrè, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dana, A.
Right arrow Articles by Gioffrè, P. A.

(Circulation. 1998;98:378-379.)
© 1998 American Heart Association, Inc.


Correspondence

Phentolamine and Preconditioning During Coronary Angioplasty

Ali Dana, BSc, MRCP; Jun-ichi Imagawa, PhD; ; Derek M Yellon, PhD, DSc, FESC, FACC

The Hatter Institute of Cardiology, UCL Hospitals & Medical School, London, UK

To the Editor:

We read with great interest the article by Tomai et al1 on the role of {alpha}-adrenergic receptors in ischemic preconditioning during coronary angioplasty. They provide evidence that pretreatment with phentolamine, a nonselective {alpha}-adrenoceptor blocking agent, abolishes the adaptation to myocardial ischemia during sequential coronary balloon inflations. The authors conclude a role for {alpha}-adrenergic receptors in mediating ischemic preconditioning in this model. This work extends previous work by the same group implicating a role for adenosine A1 receptors2 and the ATP-sensitive potassium channels (KATP)3 in ischemic preconditioning using the same model.

What the authors fail to mention in their discussion is the fact that phentolamine, independent of its {alpha}-blocking properties, has been shown to block KATP channels in insulin-producing cells,4 in vascular5 and nonvascular smooth muscle cells,6 and more recently, in cardiac ventricular myocytes.7 The involvement of KATP channels in the mechanism of ischemic preconditioning has been demonstrated in a number of animal models,8 as well as in isolated human atrial trabeculae.9 10 Furthermore, Tomai et al3 have previously shown that blockade of KATP channels abolishes the myocardial adaptation observed during sequential coronary balloon inflations. It is therefore not possible to draw any conclusions about the exact mode of action of phentolamine and consequently about the mechanisms of ischemic preconditioning during coronary angioplasty from the presented data.1 Although, as the authors suggest, the {alpha}-blocking properties of phentolamine may be responsible for the loss of adaptation to ischemia, their observations can also be explained by blockade of KATP channels . . . [Full Text of this Article]

Fabrizio Tomai, MD, FESC; Filippo Crea, MD, FACC, FESC; Achille Gaspardone, MD, FESC; ; Pier A. Gioffrè, MD, FESC

Divisione di Cardiochirurgia, Università di Roma Tor Vergata, European Hospital, Rome, Italy




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
E. M. Carvalho, E. A Gabriel, and T. A Salerno
Pulmonary Protection During Cardiac Surgery: Systematic Literature Review
Asian Cardiovasc Thorac Ann, December 1, 2008; 16(6): 503 - 507.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Huang, T. Yao, W. Wang, D. Zhu, W. Zhang, H. Chen, and W. Fu
Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass
Ann. Thorac. Surg., July 1, 2003; 76(1): 136 - 140.
[Abstract] [Full Text] [PDF]